DK174782A - Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf Download PDF

Info

Publication number
DK174782A
DK174782A DK174782A DK174782A DK174782A DK 174782 A DK174782 A DK 174782A DK 174782 A DK174782 A DK 174782A DK 174782 A DK174782 A DK 174782A DK 174782 A DK174782 A DK 174782A
Authority
DK
Denmark
Prior art keywords
procedure
acid addition
addition salts
acceptable acid
pharmaceutical acceptable
Prior art date
Application number
DK174782A
Other languages
Danish (da)
English (en)
Inventor
A J Karjalainen
K O A Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK174782A publication Critical patent/DK174782A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK174782A 1981-04-22 1982-04-20 Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf DK174782A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8112506A GB2096987B (en) 1981-04-22 1981-04-22 Substituted imidazole and imidazole derivatives and their preparation and use
GB8112506 1981-04-22

Publications (1)

Publication Number Publication Date
DK174782A true DK174782A (da) 1982-10-23

Family

ID=10521291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK174782A DK174782A (da) 1981-04-22 1982-04-20 Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (10)

Country Link
EP (1) EP0064820A1 (de)
JP (1) JPS57181063A (de)
AU (1) AU8223082A (de)
CA (1) CA1183544A (de)
DD (1) DD207375A1 (de)
DK (1) DK174782A (de)
FI (1) FI821316L (de)
GB (1) GB2096987B (de)
NO (1) NO821288L (de)
ZA (1) ZA822346B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992459A (en) * 1983-04-12 1991-02-12 Smithkline Beecham Corporation Dopamine-β-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
DE3428342A1 (de) * 1984-08-01 1986-02-13 Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
US4876266A (en) * 1987-12-31 1989-10-24 Smithkline Beckman Corporation 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors
EP0378910B1 (de) * 1988-12-15 1994-08-31 Texaco Development Corporation Verfahren zur Herstellung von Imidazolen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050520A (en) * 1960-03-31 1962-08-21 Air Prod & Chem Process of preparing 2-olefinic imidazoles
US3502661A (en) * 1967-02-14 1970-03-24 Pfizer & Co C Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
SE7605958L (sv) * 1975-05-30 1976-12-01 Scherico Ltd Nya 2-imidazoliner och deras anvendning sasom hypoglykemiska medel

Also Published As

Publication number Publication date
FI821316A7 (fi) 1982-10-23
ZA822346B (en) 1983-03-30
GB2096987A (en) 1982-10-27
JPS57181063A (en) 1982-11-08
EP0064820A1 (de) 1982-11-17
FI821316A0 (fi) 1982-04-15
AU8223082A (en) 1982-10-28
DD207375A1 (de) 1984-02-29
CA1183544A (en) 1985-03-05
NO821288L (no) 1982-10-25
FI821316L (fi) 1982-10-23
GB2096987B (en) 1984-04-04

Similar Documents

Publication Publication Date Title
DK630486A (da) Analogifremgangsmaade til fremstilling af substituerede 4-fenylalkyl- eller 4-fenylalkenylimidazolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK174782A (da) Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK198891A (da) Pyridylalkylsubstituerede ethylen- og propylendiaminer og fremgangsmaade til deres fremstilling
DK337383A (da) Fremgangsmaade til fremstilling af 4-amino-6,7-dimethoxyquinolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
DK173685A (da) Ethanolaminderivater
DK160092C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK462183D0 (da) Fremgangsmade til fremstilling af 3-(heterocyclyl eller aryl)methylthio-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
IE830142L (en) 2-(phenoxyalkyl)-imidazoles
DK91782A (da) Fremgangsmaade til fremstilling af pyridazioner eller syreadditionssalte deraf
DK98383A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
RO90620A (ro) Procedeu pentru prepararea unor saruri de piridiniu
ES549298A0 (es) Un procedimiento para la preparacion de derivados de triazol
EP0066909A3 (de) Imidazolderivate, deren pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung
DK275383A (da) Fremgangsmaade til fremstilling af 1-(2-heterocyclyl-2-(5-chlor-2-pyridyl)-2-hydroxy-ethyl)-1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
ES489353A0 (es) Un procedimiento para la preparacion de compuestos derivadosde 1-((naftil substituido)etil)imidazol
EP0211489A3 (de) 2-Fluoralkylbenzimidazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0081859A3 (de) Verfahren zur Herstellung von Cimetidin
DK194083A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK17982A (da) Fremgangsmaade til fremstilling af cycloheptenderivater
DK357683D0 (da) Fremgangsmade til fremstilling af 1-(5-chlorpyrid-2-yl)-1-(2,4-dihalogenphenyl)-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller deres farmaceutisk acceptable syreadditionssalte
EP0107293A3 (de) Dihydropyridine
DK389683D0 (da) Fremgangsmade til fremstilling af substituerede 1,3,4-benzotriazepiner eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
ATS Application withdrawn